Insider Buying: Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Director Purchases 62,516 Shares of Stock

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) Director Johan Wedell-Wedellsborg purchased 62,516 shares of the stock in a transaction that occurred on Monday, November 27th. The shares were purchased at an average price of $5.49 per share, with a total value of $343,212.84. Following the completion of the acquisition, the director now directly owns […]

Related Keywords

United States ,Johan Wedell Wedellsborg ,Rice Hall James Associates ,Morgan Stanley ,Nasdaq ,Victory Capital Management Inc ,Avestar Capital ,Acadian Asset Management ,Y Mabs Therapeutics Inc ,Jpmorgan Chase Co ,Connor Clark Lunn Investment Management Ltd ,Y Mabs Therapeutics ,Get Free Report ,Director Johan Wedell Wedellsborg ,Abs Therapeutics ,Asset Management ,Lunn Investment Management ,Hall James ,Victory Capital Management ,Y Mabs Therapeutics Daily ,Nasdaq Ymab ,Kymab ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,